期刊文献+

白血病形成中JAK/STAT信号通路的持续激活 被引量:7

Constitutive activation of JAK/STAT signaling pathway in leukemogenesis
在线阅读 下载PDF
导出
摘要 JAK/STAT通路是细胞因子、生长因子、激素等广泛应用的信号转导通路,白血病形成中普遍存在JAK/STAT通路的持续激活。白血病融合蛋白的表达、酪氨酸激酶过度表达或激活突变及某些病毒感染可导致JAK/STAT通路的持续激活和调节异常,并引起细胞的转化和白血病形成。了解白血病形成中JAK/STAT通路的异常调节有助于开发靶向JAK/STAT通路的治疗策略。 The JAK/STAT pathway that contributes to signal transduction by cytoklnes, growm factors and hormones is universally activated in leukemias. Leukemogenesis is frequently associated with the aberrant expression of activated fusion tyrosine kinases or activated protein tyrosine kinases carrying mutations. The activated kinase enzymes result in continuative activation of JAK/STAT signaling pathway. Furthermore, some virus infections are associated with dysregulation of JAK/STAT pathway. The dysregnlation of JAK/STAT pathway contributes to cellular malignant transformation and leukemogenesis. A better understanding of mechanisms of the dysregulation of JAK/STAT signaling pathway may serve as a basis for designing novel therapeutic strategies that target these pathway in leukemia cells.
出处 《国际病理科学与临床杂志》 CAS 2006年第5期398-402,共5页 Journal of International Pathology and Clinical Medicine
关键词 JAK/STAT 信号通路 持续激活 白血病形成 JAK/STAT signaling pathway consititutive activation leukemogenesis
作者简介 李英华(1971-),女,河北衡水人,硕士,主治医师,主要从事白血病/淋巴瘤的发病机制、诊断和靶向治疗的研究。
  • 相关文献

参考文献29

  • 1Rawlings J S, Rosier K M, Harrison D A. The JAK/STAT signaling pathway[J]. J Cell Sci, 2004, 117( Pt 8) :1281-1283.
  • 2Benekli M, Baer M R, Baumann H, et al. Signal transducer and activator of transcription proteins in leukemias [ J ]. Blood, 2003,101 (8) :2940-2954.
  • 3Steinberg D W, Gilliland D G. The role of signal transducer and activator of transcription factors in leukemogenesis [ J ]. J C lin Oncol, 2004, 22(2) :361-371.
  • 4Yamaoka K, Saharinen P, Pesu M, et al. The Janus kinases(Jaks) [J]. Genome Biol, 2004,5(12) :253.
  • 5Hendry L, John S. Regulation of STAT signalling by proteolytic processing[J]. Eur J Biochem, 2004, 271 (23-24):4613-4620.
  • 6Wormald S, Hilton D J. lnhibitors of cytokine signal transduction[J]. J Biol Chem, 2004,279(2) :821-824.
  • 7Frantsve J, Schwaller J, Steinberg D W, et al. SOCS-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through Inhibition of JAK2 kinase activity and induction of proteasome mediated degradation[J]. Mol Cell Biol, 2001,21 (10) :3547-3557.
  • 8Schwaller J, Frantsve J, Aster J , et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myeloid and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion gene[J]. EMBO J, 1998,17(18) :5321-5333.
  • 9Carron C, Cormier F, Janin A, et al. TEL-JAK2 transgenic mice develop T-cell leukemia [ J ]. Blood, 2000,95:3891-3899.
  • 10Kamizono S, Hanada T, Yasukawa H, et al. The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2[J]. J Biol Chem, 2001,276(16) :12530-12538.

同被引文献112

  • 1陈伟红,陈燕,崔国惠,谷俊侠,胡东,陈维凯,李新刚.姜黄素在CML原代细胞STAT5信号途径中的作用[J].中国实验血液学杂志,2004,12(5):572-576. 被引量:2
  • 2韩颖,罗建民,贾晓辉,王福旭,姚丽,杜行严.白血病患者造血细胞磷酸酶与半胱氨酸蛋白酶基因表达及其临床意义[J].中华内科杂志,2006,45(5):363-365. 被引量:18
  • 3Warmuth M,Danhauser-Riedl S,Hallek M.Molecular pathogenesis of chronic myeloid leukemia:implications for new therapeutic strategies[J].Ann Hematol,1999,78(2):49-64.
  • 4Fei F,Stoddart S,Müschen M,et al.Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia[J].Leukemia,2010,24(4):813-820.
  • 5Zheng X,Oancea C,Henschler R,et al.Reciprocal t(9;22) ABL/BCR fusion proteins:leukemogenic potential and effects on B cell Commitment[J].PLoS One,2009,4(10):e7661.
  • 6Manley P W,Cowan-Jacob S W,Mestan J,et al.Advances in the structural biology,design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia[J].Biochim Biophys Acta,2005,1754(1-2):3-13.
  • 7Pluk H,Dorey K,Superti-Furga G.Autoinhibition of c-Abl[J].Cell,2002,108(2):247-259.
  • 8Gu J J,Ryu J R,Pendergast A M.Abl tyrosine kinases in T-cell signaling[J].Immunological Reviews,2009,228:170-183.
  • 9Nagar B,Hantschel O,Young M A,et al.Structure basis for the autoinhibition of c-abl tyrosine kinase[J].Cell,2003,112(6):859-871.
  • 10Sawyers C L.Disabling Abl-Perspectives on Abl kinase regulation and cancer therapeutics[J].Cancer Cell,2002,1(1):13-15.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部